Maria Nirvana Formiga, MD, PhD (@nirvanaformiga) profile picture

Medical Oncologist @A.C.Camargo Cancer Center #oncogenetics #GUoncology #sarcoma

São Paulo, Brasil
Joined February 2018
Photo by Maria Nirvana Formiga, MD, PhD (@nirvanaformiga)Photo by Maria Nirvana Formiga, MD, PhD (@nirvanaformiga)Photo by Maria Nirvana Formiga, MD, PhD (@nirvanaformiga)Photo by Maria Nirvana Formiga, MD, PhD (@nirvanaformiga)Photo by Maria Nirvana Formiga, MD, PhD (@nirvanaformiga)Photo by Maria Nirvana Formiga, MD, PhD (@nirvanaformiga)Photo by Maria Nirvana Formiga, MD, PhD (@nirvanaformiga)Photo by Maria Nirvana Formiga, MD, PhD (@nirvanaformiga)Photo by Maria Nirvana Formiga, MD, PhD (@nirvanaformiga)Photo by Maria Nirvana Formiga, MD, PhD (@nirvanaformiga)
Maria Nirvana Formiga, MD, PhD retweeted
🤓Ok, I think you will find this interesting: How drugs should be named under the 'new' nomenclature: - Trastuzumab (Herceptin) -> Trastatug - Pembrolizumab (Keytruda) -> Pembrostotug - Atezolizumab (Tecentriq) -> Atezostobart - Blinatumomab (Blincyto) -> Blinatamig Will this happen? Well, not with older drugs, but certainly with new ones. If you want to learn more about this naming system, check out this thread!
1
8
1
18
3,070
Maria Nirvana Formiga, MD, PhD retweeted
In >230,000 individuals from the Helix Research Network, Lynch syndrome cancer risk varied substantially by gene @JCOOA_ASCO @kellyschiabor MLH1/MSH2 showed the highest colorectal cancer risk, while PMS2 demonstrated markedly lower penetrance & later onset ascopubs.org/doi/pdf/10.1200…
11
22
1,543
Maria Nirvana Formiga, MD, PhD retweeted
For the 1st time in history, there are more people >65 than <5 globally Cancer care is aging and we’re not ready As @WilliamDale_MD highlighted: geriatric + palliative care must become core, not optional @PallOncCoP @realbowtiedoc @RyanNipp @IshwariaMD @DarcyBurbage @JamesFanWu
8
10
282
Maria Nirvana Formiga, MD, PhD retweeted
Just started👉2025 United States #ProstateCancer Consensus Conference (USPCCC) 👉with @AlanBryce9 ‘s introductory remarks. @philkuo @cityofhope debating for PSMA PET for treatment selection. Caveat👉 Medical conditions with false positive PSMA PET lesions 👇@urotoday @PCFnews
7
21
3
56
14,294
Socioeconomic inequities in prostate cancer care: private versus public treatment settings pose a significant impact on overall survival doi.org/10.31744/einstein_jo… influence of drug access on #overalsurvival #prostatecancer @lucianaholtz @StenioZequi
1
1
99
Maria Nirvana Formiga, MD, PhD retweeted
1
3
104
Excellent overview 1st line therapy in #renalcellcarconoma . Always brilliant talk by @montypal @AlbigesL At #ESMO2024
1
6
140
Maria Nirvana Formiga, MD, PhD retweeted
Wonderful time with colleges from México and Brazil diving in thee prostate cancer Journey @acccancercenter @StenioZequi José Augusto Rinck @thiagocmourao Daniel Garcia @nirvanaformiga @AldoLADETTINO @luciana45069110 @ederbrazaojr Rafael Zanotti – at Sao Paulo, Brazil
3
1
9
685
#prostatecancer @OncologyBio Excelente evento de discussão de câncer de próstata! @SoaresAndrey
6
98
Maria Nirvana Formiga, MD, PhD retweeted
Huge congrats to #NizarTannirMD @MDAndersonNews who drove forward this impt trial (#PIVOT09) comparing pegylated #IL2/#nivolumab to #TKI; was a privelege to work w him & others (@nirvanaformiga @neerajaiims @Daniel_J_George) on this trial now in @JCO_ASCO. PFS & OS no different; RR a bit lower in experimental arm. We saw @brian_rini & @DrChoueiri present genomic data from #KN426 & #CLEAR at #ASCO24 & prev saw genomic data from #CM214 presented by @motzermd. Wish we had the opportunity to look at that here - given modest activity w #bempeg, could offer insights on which pts could get IO monotx - something we discuss often after #KN427 but do infrequently in practice.
4
29
2
71
13,261
Congrats @crisbergerot for presenting data on #HRQoL in #kidneycancer #GU24 @ASCO Elegant and necessary trial mentored by @tompowles1 @montypal – at San Francisco, CA
3
8
400